Coronary artery spasm and vascular biology. Cholinergic constriction.
Coronary artery spasm is undoubtedly one of the causative factors of ischemic heart disease, particularly variant-type angina pectoris and myocardial infarction, but the disease mechanisms involved are still unclear. The present review describes the clinical background of coronary artery spasm in relation to ischemic heart disease, including a brief history of studies in this field, and also suggests future guidelines for experimental investigations based on the characteristics of coronary artery spasm, focusing particularly on data we have obtained in our laboratory from studies of cholinergic constriction. The pig may be a suitable animal in which coronary artery spasm could be provoked with cholinergic agents following endothelial denudation. The use of such large animals would allow the study of spastic arterial segments by various methods with angiographic confirmation. After endothelial denudation it is possible that phenotypic changes in cholinergic receptors might occur in smooth muscle cells, and that such changes might remain even after endothelial repair.
Sakurai
I
I
Department of Pathology, Nihon University School of Medicine, Tokyo, Japan.
D000109:Acetylcholine; D000818:Animals; D003251:Constriction, Pathologic; D003324:Coronary Artery Disease / Q000209:etiology / Q000503:physiopathology*; D003327:Coronary Disease / Q000209:etiology / Q000503:physiopathology*; D003329:Coronary Vasospasm / Q000473:pathology / Q000503:physiopathology*; D004730:Endothelium, Vascular / Q000503:physiopathology*; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000503:physiopathology; D011976:Receptors, Muscarinic / Q000502:physiology*; D013552:Swine
D011976:Receptors, Muscarinic; D000109:Acetylcholine